openPR Logo
Press release

Drug of Abuse Testing Pharmaceutical and Healthcare Analysis Information 2020

11-20-2018 10:50 AM CET | Health & Medicine

Press release from: Market Research Future - MRFR

/ PR Agency: Market Research Future
Global Drug of Abuse Testing Market - Overview
The use of illicit drugs is rising every year globally and has become a big concern for countries including the U.S., the U.K. Japan, Germany, India and China. Illicit drugs in use include heroin, cannabis, cocaine, ecstasy and amphetamine. Global cocaine seizures increased to 671 tons in 2012, compared with the 634 tons seized in 2011. The main increase in the quantities of cocaine seized was in South America and Western and Central Europe. Some of the new psychoactive substances (NPS) like, phenethylamines, ketamine, piperazine and tryptamines, are also being used widely in the drug market.

GET SAMPLE REPORT @ https://www.marketresearchfuture.com/sample_request/1930

Further Drug trafficking is a global illicit trade involving the cultivation, manufacture, distribution and sale of substances which are subject to drug prohibition laws. According to United Nations Office on Drugs and Crime (UNODC) estimates, drug trafficking is increasing worldwide due to rising demand of illicit drugs (mainly heroin, cocaine and amphetamines). World heroin consumption and seizures represent an annual flow of 430 tons to 450 tons of heroin in the global heroin market.

According to data from the UNODC and European crime-fighting agency Europol, the annual global drugs trade is worth around $435.0 billion a year, with the annual cocaine trade worth $84 billion. With the exception of opiate use, use of all other groups of substances (opioids, cannabis, cocaine, ATS and ecstasy) remains at level higher than the global average in the region. In the U.S., illicit drug use by persons aged 12 years or older reached the highest level in the past 10 years, increasing from 15.0% in 2011 to 16.0% in 2012.

The overall demand for drug of abuse testing is rising and the same is being used mostly by healthcare service providers, public and private organizations and other government agencies. The two major technologies used for onsite screening testing and laboratory testing of drug of abuse are immunoassay technique and chromatography.

Global Drug of Abuse Testing Market – Industry Updates
In November 2017, Thermo Fisher Scientific announced the newest library update for the Thermo Scientific TruNarc handheld narcotics analyser which can now detect Carfentanil. As part of the software update, the TruNarc analyzer adds 45 new substances, including 14 new forms of fentanyl, to its onboard library.

In August 2016, Thermo Fisher Scientific announced that a new immunoassay for the specific detection of hydrocodone has received 510 (k) clearance from the U.S. Food and Drug Administration (FDA).

Market Key Players:
Roche Holding Limited,
Quest Diagnostics,
Laboratory Corporation of America Holdings,
Alere Inc.,
Abbott Laboratories,
Randox Laboratories Ltd,
Psychemedics Corporation,
Bio-Rad Laboratories,
Inc, Sonic Healthcare and Thermo Fisher Scientific Inc. and others

Global Drug of Abuse Testing Market - Regional Analysis
In North America, the usage of cocaine has been declining since 2006, partly due to a sustained shortage. However, more recently, a slight increase in prevalence of cocaine has been observed in the U.S., as there has been an increase in maritime seizures.

In Europe, cannabis is by far the most commonly consumed illicit substance, with an estimated 24 million users (4.3% of those aged 15 years to 64 years), followed by cocaine with 3.7 million users in 2013.

In Europe, the market has changed over the past decade, with cannabis herb produced locally or regionally now gaining ground over cannabis resin, largely sourced from Morocco, which previously was the dominant cannabis substance in Europe.

It appears that the flow of heroin along the long-established Balkan route, from Afghanistan to Western and Central Europe via Iran and Turkey, has declined in recent years. Some of the factors contributing to the decline in seizures along this route include the success of law enforcement authorities in key transit countries and a decline in demand in the destination market.

In Asia, it is estimated that cannabis is the most common illicit substance, with an annual prevalence of use of 1.9%, followed by ATS (excluding ecstasy) at 0.7%, ecstasy at 0.4%, opiates at 0.4% and cocaine at 0.1%, among those aged 15-64 years. The use of methamphetamine continues to rise in most of the countries in East and South-East Asia, with accompanying seizures of methamphetamine in pill and crystalline forms reaching record levels in 2012. It has been indicated that in East and South-East Asia, the use of ATS has both increased and diversified. ATS has been ranked among the three predominately used drug types in countries in the sub-region since 2009.

Table of Content: Key Points
1 Research Scope & Methodology
2 Executive Summary
3 Market Outlook
4 Global Market Size & Forecast (2011-2020
5 Global Market Breakdown by Type of Test
6 Global Market Breakdown by Sample
7 Global Market Breakdown by Region
8 Competitive Analysis and Market Share
9 Company Profiles
10 Appendix
11 List of Tables
12 List of Figures
…Continued

Enquire now @ https://www.marketresearchfuture.com/reports/drug-abuse-testing-market-1930

Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Drug of Abuse Testing Pharmaceutical and Healthcare Analysis Information 2020 here

News-ID: 1384685 • Views:

More Releases from Market Research Future - MRFR

Commercial Seaweeds Market, Key Company, Trends, Size, Emerging Technologies, Growth Factors, And Regional Forecast To 2027
Commercial Seaweeds Market, Key Company, Trends, Size, Emerging Technologies, Gr …
Market Highlights Commercial seaweeds are marine algae with applications in foods, animal feeds, and fertilizers. They are rich in vitamins making them a vital component in processed foods. The global commercial seaweeds market report by Market Research Future (MRFR) has been compiled by observing the changing food habits of consumers as well as abundance of seaweeds for production of processed foods. The report contains estimations and predictions for the period of
Dairy Beverages Market, Production and Consumption Analysis, Brands Statistics and Overview by Top Manufacturers 2027
Dairy Beverages Market, Production and Consumption Analysis, Brands Statistics a …
Market Scope The global dairy beverages market is set to reach a value of USD 91 billion by 2024. With the need for beverages to serve as meal replacement meals for post-gym session, the market is expected to capitalize on this trend. Introduction of new flavors as well as preference of yogurt and whey drinks are likely to drive the market demand exponentially. High demand for ready-to-drink (RTD) beverages and launch
Snack Pellets Market: Industry Development Challenges, Opportunities, Market Entry Strategies, Key Manufacturers Analysis 2027
Snack Pellets Market: Industry Development Challenges, Opportunities, Market Ent …
Market-Overview The escalating intake of convenience food products is foreseen to enhance the snack pellets market. The food, beverages & nutrition reports are made by Market Research Future, which includes market options for expansion. A motivating CAGR is foreseen to drive the evolution of the market in the near future. The accessibility to raw ingredients such as potato, tapioca, and grains more easily is anticipated to create an encouraging market for snack
Herbal Tea Market, Opportunity Assessment, Future Estimations and Key Industry Segments Poised for Strong Growth in Future 2027
Herbal Tea Market, Opportunity Assessment, Future Estimations and Key Industry S …
Market Scope Market Research Future (MRFR) expects the herbal tea market 2020 to blossom at a rate of 4.94% from 2017 to 2025 (evaluation period). MRFR also anticipates that the market for herbal tea can accrue a valuation of USD 4,226.9 Million by 2025. We will provide COVID-19 impact analysis with the report, along with all the extensive key developments in the market post the coronavirus disease outbreak. Top Boosters and Deterrents The

All 5 Releases


More Releases for Drug

Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drug
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.  Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June. The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug